Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
Conventional systematic biopsy has the shortcoming of sampling error and reveals “no evidence of cancer” with a rate of >50% on active surveillance (AS). researchers have studied to report their initial experience of applying a 3D-documented biopsy-mapping technology to precisely re-visit geographically documented low-risk prostate cancer and to perform serial analysis of cell-cycle-progression (CCP) gene-panel.
Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi